HC Wainwright & Co. Initiates Coverage On Genelux with Buy Rating, Announces Price Target of $35
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Emily Bodnar has initiated coverage on Genelux Corporation (NASDAQ:GNLX) with a Buy rating and set a price target of $35.
November 27, 2023 | 12:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Genelux Corporation received a Buy rating from HC Wainwright & Co. with a price target of $35, indicating a positive outlook from the analyst.
The initiation of coverage by an analyst with a Buy rating typically suggests a positive outlook on the stock's future performance. The price target of $35 implies a significant upside potential from the current trading price, which may attract investor interest and potentially drive up the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100